Table 2 Factors associated with Gram-negative bacterial infection among study participants

Age

  <  = 5 years

4(4.4)

2(2.8)

0.80(0.11–6.10)

–

 6–17 years

3(3.3)

3(4.2)

1.60(0.23–11.27)

–

 18–29 years

14(15.6)

4(5.6)

0.46(0.10–2.21)

–

 30–41 years

19(21.1)

10(13.9)

0.84(0.22–3.26)

 42–53 years

27(30.0)

23(31.9)

1.36(0.39–4.75)

 54–65 years

15(16.7)

25(34.7)

2.67(0.74–9.67)

  >  = 65 years

8(8.9)

5(6.9)

Ref.

Gender

 Male

53(58.9)

51(70.8)

0.59(0.31–1.14)

0.51(0.24–1.09)

 Female

37(41.1)

21(29.2)

Ref.

Ref.

Pathology

 Respiratory tract conditions

16(17.8)

20(27.8)

2.5(0.96–6.50)

5.3(1.67–16.75)

 CVD

19(21.1)

8(11.1)

4.5(1.15–17.65)

5.69(1.25–25.81)

 Cancer

11(12.2)

9(12.5)

1.64(0.53–5.02)

2.63(0.7–9.92)

 Brain infection

4(4.4)

9(12.5)

1.2(0.25–5.87)

1.15(0.34–3.91)

 GIT infection

5(5.6)

3(4.2)

3.5(0.85–14.34)

1.61(0.26–10.09)

 Kidney disorder

4(4.4)

7(9.7)

1.14(0.28–4.68)

3.9(0.82–18.66)

 Fractures

7(7.8)

4(5.6)

1.11(0.56–3.22)

1.14(0.23–5.6)

 Others

24(26.7)

12(16.7)

Ref.

Ref.

Referral status

 Yes

34(37.8)

15(20.8)

2.31(1.13–4.70)

2.15(0.87–5.33)

 No

56(62.2)

57(79.2)

Ref.

Ref.

LOS

 Short (≤ 5 days)

39(43.3)

37(51.4)

Ref

 Median (6—10 days)

31(34.4)

24(33.3)

1.73(0.73–4.086)

-

 Long (> 10 days)

20(22.2)

11(15.3)

1.41(0.57–3.49)

-

Prior antibiotics use within last 30 days

 Yes

69(76.7)

37(51.4)

3.11(1.59–6.09)

4.23(1.77–10.11)

 No

21(23.3)

35(48.6)

Ref.

Ref.

Invasive procedure

 Yes

67(74.4)

49(68.1)

1.37(0.69–2.71)

–

 No

23(25.6)

23(31.9)

Ref.

Prior hospitalization in the last 30 days

 Yes

56(62.2)

36(50)

1.65(0.88–3.09)

–

 No

34(37.8)

36(50)

Ref.

Using NGT

 Yes

39(43.3)

14(19.4)

3.16(1.55–6.49)

3.04(1.26–7.32)

 No

51(56.7)

58(80.6)

Ref.

Ref.